Lowe, P. J., Tannenbaum, S., Gautier, A., & Jimenez, P. (2009). Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma. Blackwell Science Inc.
Chicago ZitierstilLowe, Philip J., Stacey Tannenbaum, Aurelie Gautier, und Pablo Jimenez. Relationship between Omalizumab Pharmacokinetics, IgE Pharmacodynamics and Symptoms in Patients With Severe Persistent Allergic (IgE-mediated) Asthma. Blackwell Science Inc, 2009.
MLA ZitierstilLowe, Philip J., Stacey Tannenbaum, Aurelie Gautier, und Pablo Jimenez. Relationship between Omalizumab Pharmacokinetics, IgE Pharmacodynamics and Symptoms in Patients With Severe Persistent Allergic (IgE-mediated) Asthma. Blackwell Science Inc, 2009.